MDVLQ (MedAvail Holdings) Change In Receivables: $0.63 Mil (TTM As of Jun. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MDVLQ MedAvail Holdings Inc MDVLQ
12 GF Score
Price $0.00
View Full Analysis

What is MedAvail Holdings Change In Receivables?

MedAvail Holdings MDVLQ 12 Change In Receivables is $0.63 Mil as of Jun. 2023. GuruFocus rates MDVLQ with a GF Score™ of 12/100.

MedAvail Holdings's change in receivables for the quarter that ended in Jun. 2023 was $0.98 Mil. It means MedAvail Holdings's Accounts Receivable declined by $0.98 Mil from Mar. 2023 to Jun. 2023 .

MedAvail Holdings's change in receivables for the fiscal year that ended in Dec. 2022 was $-1.19 Mil. It means MedAvail Holdings's Accounts Receivable increased by $1.19 Mil from Dec. 2021 to Dec. 2022 .

MedAvail Holdings's Accounts Receivable for the quarter that ended in Jun. 2023 was $0.29 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. MedAvail Holdings's Days Sales Outstanding for the three months ended in Jun. 2023 was 65.79.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. MedAvail Holdings's liquidation value for the three months ended in Jun. 2023 was $12.75 Mil.

MedAvail Holdings  (OTCPK:MDVLQ) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

MedAvail Holdings's Days Sales Outstanding for the quarter that ended in Jun. 2023 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=0.292/0.405*91
=65.79

2. In Ben Graham's calculation of liquidation value, MedAvail Holdings's accounts receivable are only considered to be worth 75% of book value:

MedAvail Holdings's liquidation value for the quarter that ended in Jun. 2023 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=14.359-6.863+0.75 * 0.292+0.5 * 10.065
=12.75

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MedAvail Holdings Change In Receivables Related Terms

MedAvail Holdings Change In Receivables Historical Data

* Premium members only.

The historical data trend for MedAvail Holdings's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MedAvail Holdings Change In Receivables Chart

MedAvail Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Change In Receivables
-0.29 -1.35 0.25 -1.19

MedAvail Holdings Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.36 -0.25 0.00 -0.10 0.98
MDVLQ
12GF Score
MedAvail Holdings Inc MDVLQ
Change In Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MedAvail Holdings Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.63 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Receivables →
What does a Change In Receivables of $0.63 Mil mean?
MedAvail Holdings (MDVLQ) has a Change In Receivables of $0.63 Mil as of Jun. 2023. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for MedAvail Holdings and its competitors.
Is MedAvail Holdings' Change In Receivables too high?
MedAvail Holdings' current Change In Receivables is $0.63 Mil. Overall, MedAvail Holdings has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does MedAvail Holdings' Change In Receivables compare to HEWA and BIMI?
MedAvail Holdings' Change In Receivables of $0.63 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for a Healthcare Providers & Services company?
A good Change In Receivables depends on the Healthcare Providers & Services industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for MedAvail Holdings and its competitors. MedAvail Holdings's current Change In Receivables is $0.63 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedAvail Holdings stock overvalued right now?
MedAvail Holdings (MDVLQ) has a current Change In Receivables of $0.63 Mil. The current Change In Receivables is $0.63 Mil. MedAvail Holdings' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For MedAvail Holdings (MDVLQ), the current Change In Receivables is $0.63 Mil as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MedAvail Holdings Business Description

Address 4720 East Cotton Gin Loop, Suite 220, Phoenix, AZ, USA, 85040
MedAvail Holdings Inc is a telehealth-enabled pharmacy technology company. It operates in two segments: Retail Pharmacy Services and Pharmacy Technology. It generates the majority of revenue from the Retail Pharmacy Services segment, which is into operating SpotRx, a full-service retail pharmacy utilizing MedAvail's automated pharmacy technology, servicing Medicare patients in the United States. The Pharmacy Technology segment develops and commercializes the MedCenter for direct sale or lease to third-party customers.
12GF Score

Get the complete analysis for MDVLQ

Change In Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price